These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23532311)

  • 1. [Innovation in pharmaceutical and health biotechnology industries: challenges for a virtuous agenda].
    Vargas M; Gadelha CA; Costa LS; Maldonado J
    Rev Saude Publica; 2012 Dec; 46 Suppl 1():37-40. PubMed ID: 23532311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Windows of opportunities and technological innovation in the Brazilian pharmaceutical industry.
    Tigre PB; Nascimento CV; Costa LS
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00103315. PubMed ID: 27828675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.
    Vasconcellos AG; Morel CM
    PLoS One; 2012; 7(10):e45569. PubMed ID: 23056208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical lobbying in Brazil: a missing topic in the public health research agenda.
    Paumgartten FJ
    Rev Saude Publica; 2016 Dec; 50():70. PubMed ID: 28099661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent changes and continuity of technological and economic dependency in the pharmaceutical industry in Brazil].
    Rodrigues PHA; Silva RDFDC; Kiss C
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00104020. PubMed ID: 36043624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Brazilian phytotherapics industry: challenges and opportunities.
    Hasenclever L; Paranhos J; Costa CR; Cunha G; Vieira D
    Cien Saude Colet; 2017 Aug; 22(8):2559-2569. PubMed ID: 28793072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare systems, the State, and innovation in the pharmaceutical industry.
    Delgado IJ
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00037415. PubMed ID: 27828672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health and innovation: economic dynamics and Welfare State in Brazil.
    Gadelha CA; Braga PS
    Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00150115. PubMed ID: 27828678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Historical sketch of modern pharmaceutical science and technology (Part 4). Post World War II 50 years].
    Yamakawa K
    Yakushigaku Zasshi; 1995; 30(2):75-90. PubMed ID: 11613536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Generic drugs in Brazil: impacts of public policies upon the national industry].
    Quental C; de Abreu JC; Bomtempo JV; Gadelha CA
    Cien Saude Colet; 2008 Apr; 13 Suppl():619-28. PubMed ID: 21936166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health and development in Brazil: progress and challenges].
    Gadelha CA; Costa LS
    Rev Saude Publica; 2012 Dec; 46 Suppl 1():13-20. PubMed ID: 23250394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health and innovation: a systemic approach in health industries].
    Gadelha CA; Quental C; Fialho Bde C
    Cad Saude Publica; 2003; 19(1):47-59. PubMed ID: 12700783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can a policy foster local pharmaceutical production and still protect public health? Lessons from the health-industry complex in Brazil.
    da Fonseca EM
    Glob Public Health; 2018 Apr; 13(4):489-502. PubMed ID: 29098942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Paranhos J; Hasenclever L; Perin FS
    J Law Med Ethics; 2023; 51(S1):126-135. PubMed ID: 38156350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production and R&D structure of the Brazilian pharmaceutical industry: the role of public procurement and public drug production.
    Sorte Junior WF
    Glob Public Health; 2012; 7(10):1062-79. PubMed ID: 22950510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Horus: technological innovation in pharmaceutical assistance within the Brazilian unified health system].
    Costa KS; Nascimento JM
    Rev Saude Publica; 2012 Dec; 46 Suppl 1():91-9. PubMed ID: 23250393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.